Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Akebia Therapeutics (AKBA) Income from Continuing Operations (2016 - 2026)

Akebia Therapeutics has reported Income from Continuing Operations over the past 10 years, most recently at 12244000.0 for Q4 2025.

  • Quarterly Income from Continuing Operations rose 46.31% to 12244000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5345000.0 through Dec 2025, up 92.3% year-over-year, with the annual reading at 5345000.0 for FY2025, 92.3% up from the prior year.
  • Income from Continuing Operations was 12244000.0 for Q4 2025 at Akebia Therapeutics, down from 540000.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 29038000.0 in Q2 2022 and troughed at 84303000.0 in Q2 2021.
  • The 5-year median for Income from Continuing Operations is 16237000.0 (2023), against an average of 25379100.0.
  • Year-over-year, Income from Continuing Operations surged 134.44% in 2022 and then tumbled 3814.01% in 2024.
  • A 5-year view of Income from Continuing Operations shows it stood at 70422000.0 in 2021, then soared by 90.76% to 6505000.0 in 2022, then skyrocketed by 109.44% to 614000.0 in 2023, then tumbled by 3814.01% to 22804000.0 in 2024, then soared by 46.31% to 12244000.0 in 2025.
  • Per Business Quant, the three most recent readings for AKBA's Income from Continuing Operations are 12244000.0 (Q4 2025), 540000.0 (Q3 2025), and 247000.0 (Q2 2025).